[go: up one dir, main page]

ES521728A0 - Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. - Google Patents

Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Info

Publication number
ES521728A0
ES521728A0 ES521728A ES521728A ES521728A0 ES 521728 A0 ES521728 A0 ES 521728A0 ES 521728 A ES521728 A ES 521728A ES 521728 A ES521728 A ES 521728A ES 521728 A0 ES521728 A0 ES 521728A0
Authority
ES
Spain
Prior art keywords
sultamicilina
benzenosulphonic
salt
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521728A
Other languages
English (en)
Other versions
ES8406075A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES521728A0 publication Critical patent/ES521728A0/es
Publication of ES8406075A1 publication Critical patent/ES8406075A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES521728A 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. Expired ES8406075A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (2)

Publication Number Publication Date
ES521728A0 true ES521728A0 (es) 1984-07-01
ES8406075A1 ES8406075A1 (es) 1984-07-01

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521728A Expired ES8406075A1 (es) 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Country Status (27)

Country Link
US (1) US4432987A (es)
EP (1) EP0092968B1 (es)
JP (1) JPS58201792A (es)
KR (1) KR860001279B1 (es)
AU (1) AU536854B2 (es)
CA (1) CA1187484A (es)
CS (1) CS235320B2 (es)
DD (1) DD209632A5 (es)
DE (1) DE3362502D1 (es)
DK (1) DK162168C (es)
EG (1) EG16412A (es)
ES (1) ES8406075A1 (es)
FI (1) FI76092C (es)
GR (1) GR78582B (es)
HK (1) HK20588A (es)
HU (1) HU187068B (es)
IE (1) IE54628B1 (es)
IL (1) IL68453A (es)
NO (1) NO156202C (es)
NZ (1) NZ203988A (es)
PH (1) PH18035A (es)
PL (1) PL134978B1 (es)
PT (1) PT76587B (es)
SG (1) SG104087G (es)
SU (1) SU1138030A3 (es)
YU (1) YU43170B (es)
ZA (1) ZA832845B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上（およびスペクトルシフト）のためのポリキレ−ト剤
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
PL374664A1 (en) 2002-08-29 2005-10-31 Taisho Pharmaceutical Co, Ltd. Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
EP1606293B1 (en) * 2003-03-27 2009-08-19 Basilea Pharmaceutica AG Cephalosporin in crystalline form
CA2543181A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
SA08290520B1 (ar) 2007-08-22 2012-02-22 استرازينيكا ايه بي مشتقات سيكلو بروبيل أميد وتركيبات صيدلية تحتوي عليها لعلاج حالة مرضية سببها مستقبلات هيستامين h3
WO2009055053A2 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
CA2750565C (en) * 2009-01-30 2015-10-20 Glaxosmithkline Llc Crystalline n-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CA2767785A1 (en) * 2009-07-10 2011-01-13 Evolva Ag Diyne compositions
BR112012020780A2 (pt) * 2010-02-18 2016-05-03 Astrazeneca Ab forma sólida, composição farmacêutica, e, uso de uma forma sólida.
WO2011102795A1 (en) 2010-02-18 2011-08-25 Astrazeneca Ab New crystalline form of a cyclopropyl benzamide derivative
CN104903289B (zh) * 2012-12-03 2017-06-09 株式会社钟化 还元型辅酶q10衍生物及其制造方法
KR102177643B1 (ko) * 2013-09-05 2020-11-11 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
CN111888368B (zh) * 2014-10-21 2024-02-02 武田药品工业株式会社 5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的晶形
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
EP3778567A1 (en) * 2016-01-22 2021-02-17 Sandoz Ag Crystalline eravacycline bis-hydrochloride
KR20190025989A (ko) 2016-07-07 2019-03-12 아이언우드 파마슈티컬스, 인코포레이티드 sGC 자극제의 고체 형태
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
CN117120034A (zh) * 2021-02-15 2023-11-24 普洛佩拉治疗公司 阿比特龙前药
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
KR20240004588A (ko) * 2021-05-12 2024-01-11 제지앙 롱샴 바이오-테크 파르마. 씨오., 엘티디. 피롤로피리미딘류 화합물의 결정형 및 이의 제조 방법
US11851424B2 (en) * 2021-05-14 2023-12-26 Global Blood Therapeutics, Inc. Solid forms of a modulator of hemoglobin
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
US12410155B2 (en) * 2021-12-28 2025-09-09 Zhejiang Yangli Pharmaceutical Technology Co., Ltd. Salt form and crystal form of tetrahydrocyclohepta indazole compound
US20250388537A1 (en) * 2022-05-20 2025-12-25 Caamtech, Inc. Tryptamine derivatives
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301173S (en) 2023-04-28 2024-06-26 Hs Produkt D O O Firearm
TW202517651A (zh) * 2023-07-17 2025-05-01 美商庫拉腫瘤技術股份有限公司 Menin抑制劑之晶型
AU2024292423A1 (en) * 2023-07-17 2026-01-22 Kura Oncology, Inc. Pharmaceutical compositions comprising a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US4432987A (en) 1984-02-21
FI831392A0 (fi) 1983-04-22
DK162168B (da) 1991-09-23
AU536854B2 (en) 1984-05-24
YU43170B (en) 1989-04-30
DK162168C (da) 1992-03-02
NO156202C (no) 1987-08-19
PT76587B (en) 1986-02-27
IE54628B1 (en) 1989-12-20
DE3362502D1 (en) 1986-04-17
EP0092968B1 (en) 1986-03-12
PT76587A (en) 1983-05-01
FI831392L (fi) 1983-10-24
CS235320B2 (en) 1985-05-15
KR840004437A (ko) 1984-10-15
DK101783D0 (da) 1983-02-28
YU90483A (en) 1986-04-30
CA1187484A (en) 1985-05-21
DK101783A (da) 1983-10-24
PL134978B1 (en) 1985-09-30
KR860001279B1 (ko) 1986-09-05
EG16412A (en) 1989-03-30
JPS58201792A (ja) 1983-11-24
JPH0119395B2 (es) 1989-04-11
IL68453A (en) 1986-08-31
GR78582B (es) 1984-09-27
ES8406075A1 (es) 1984-07-01
SU1138030A3 (ru) 1985-01-30
ZA832845B (en) 1984-11-28
IE830926L (en) 1983-10-23
AU1387183A (en) 1983-11-17
EP0092968A1 (en) 1983-11-02
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
PH18035A (en) 1985-03-06
PL241553A1 (en) 1983-11-21
FI76092C (fi) 1988-09-09
FI76092B (fi) 1988-05-31
HU187068B (en) 1985-11-28
HK20588A (en) 1988-03-25
NO156202B (no) 1987-05-04
DD209632A5 (de) 1984-05-16
SG104087G (en) 1988-07-15
IL68453A0 (en) 1983-07-31

Similar Documents

Publication Publication Date Title
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES520671A0 (es) Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES509010A0 (es) Un procedimiento para la produccion de un dl- amino acido o una sal correspondiente.
ES519322A0 (es) Procedimiento para la preparacion de derivados de acidos difosfonicos.
ES521692A0 (es) Un procedimiento para la preparacion de (-)-(r)-1-hidroxi-2--(r-1-metil-3-fenilpropril-aminoetil-salicilamida o una sal de adicion de acido respectiva.
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES521337A0 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES522883A0 (es) "procedimiento para la preparacion de un ester basico de acido 1, 4-dihidropiridin-3,5-dicarboxilico"
ES535625A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma
ES522403A0 (es) Un procedimiento para la preparacion de nuevos compuestos derivados de aziridina.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES518137A0 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES543491A0 (es) Un procedimiento para la preparacion de una sal metalica de un monoalquilfosfato.
ES500322A0 (es) Procedimiento para la preparacion de un acido bencenocarbo- xilico
ES523786A0 (es) Procedimiento para la preparacion de derivados de acidos difosfonicos.
ES517285A0 (es) Procedimiento para la preparacion de acido metacrilico.
ES523136A0 (es) Un procedimiento para la preparacion de un compuesto.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.
ES538906A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido tiazolilacetico.
ES523869A0 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.
ES525238A0 (es) Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos.
ES522388A0 (es) Un procedimiento para la preparacion de heptahidrato de 7b-(2d-2-amino-2-carboxietiiitioacetamido-7&-metoxi-3-(1-metil- 1h-tetrazol-5-il)tiometil-3-cefem-4-carboxilato sodico.